Irshad Ahmad

Dr. Irshad Ahmad


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Bioorganic Chemistry
Verified
Journal Article
Closed access
AHAsad Hamad
Asad Hamad
MKMohsin Abbas Khan
Mohsin Abbas Khan
KRKhondaker Miraz Rahman
Khondaker Miraz Rahman
IAIrshad Ahmad
Irshad Ahmad
Zaheer Ul-HaqZaheer Ul-Haq
Zaheer Ul-Haq
ZSZahid Shafiq
Zahid Shafiq

1 January 2019 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
HAHassan H. Abdallah
Hassan H. Abdallah
Thet Thet HtarThet Thet Htar
Thet Thet Htar
RNRakesh Naidu
Rakesh Naidu
NNNurziana Sharmilla Nawawi
Nurziana Sharmilla Nawawi
IAIrshad Ahmad
Irshad Ahmad
Nafees AhemadNafees Ahemad
Nafees Ahemad

13 March 2020 in Processes
Verified
Journal Article
Open access
PDF file
HShammad saleem
hammad saleem
MSMuhammad Sarfraz
Muhammad Sarfraz
HAHafiz Muhammad Ahsan
Hafiz Muhammad Ahsan
UKUmair Khurshid
Umair Khurshid
SKSyed Asif Jahanzeb Kazmi
Syed Asif Jahanzeb Kazmi
Kannan RR RengasamyKannan RR Rengasamy
Kannan RR Rengasamy
This research endeavors to inspect the chemical and biological profiling of methanol and dichloromethane (DCM) extracts prepared from Abutilon figarianum Webb. Total bioactive constituents and secondary metabolites were assessed via ultra-high performance liquid chromatography (UHPLC-MS). Biological effects were evaluated via antioxidant and enzymes inhibitory assays. The methanol extract was able to give the highest phenolic (51.92 mg GAE/g extract) and flavonoid (72.59 mg QE/g extract) contents and was found to contain 11 bioactive metabolites, including flavonoid, alkaloid, phenolic and fatty acid derivatives, as accessed by UHPLC-MS analysis. Similarly, the phytochemical profiling of the DCM extract tentatively identified the 12 different secondary metabolites, most of these were fatty acid derivatives. The methanol extract was most active in the radical scavenging, reducing power and total antioxidant power assays, while dichloromethane extract showed the highest metal chelating activity. For enzyme inhibition, the DCM extract showed the highest activity against cholinesterases, glucosidase and amylase, whereas methanol extract was most active against tyrosinase. Docking studies have supported the observed biological activity, where isobergapten showed higher activity against tyrosinase (−7.63 kcal/mol) with inhibition constant (2.55 µM), as opposed to other enzymes. The observed antioxidant and inhibitory potentials of A. figarianum against the studied enzymes tend to endorse this plant as a prospective source of bioactive phytochemicals.

18 May 2016
Verified
Journal Article
Closed access
HShammad saleem
hammad saleem
IAIrshad Ahmad
Irshad Ahmad
MSMuhammad Nabeel Shahid
Muhammad Nabeel Shahid
MGMuhammad Shoaib Ali Gill
Muhammad Shoaib Ali Gill
MNMuhammad Faisal Nadeem
Muhammad Faisal Nadeem
IRImran Rashid
Imran Rashid


27 April 2022 in Tropical Journal of Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
TITaha Iqbal
Taha Iqbal
MKMohsin Abbas Khan
Mohsin Abbas Khan
IAIrshad Ahmad
Irshad Ahmad
FKFahad Mehmood Khan
Fahad Mehmood Khan
Purpose: To synthesize anticonvulsant drug derivatives that target protease-activated receptor generated epileptic seizures.Method: Varieties of carbamazepine-based Schiff bases were designed with different aldehydes and ketones, and evaluated for in silico computer-aided drug design prediction of absorption, distribution, metabolism and excretion (ADME), and potential drug targets. The resultant compounds were synthesized and characterized by various spectroscopic techniques, including FTIR, 1H-NMR and 13CNMR, analysis. Thereafter, they were screened for antimicrobial, antioxidant and anticonvulsant potential.Results: Prominent anti-protease potential was shown by C7 and C3 compounds and the order of activity was C7 > C3 > C5 > C2 > C6 > C4 > C2 > C1 (p < 0.05). The anticonvulsant activity of C7 and C5 was comparable with the standard drug; C3, C4, C6 and C8 had mild activity while C1 and C4 showed the least activity. The synthesized compounds exhibited significant (p < 0.05) antioxidant potential (rank order: C3 > C4 > C5 > C7 > C8 > C6 > C1 > C2) and antimicrobial activity against S.aureus and B. bronchiseptica (rank order: C5 > C2 > C8 > C1 > C4 > C3 > C7).Conclusion: Synthesized derivatives retained their potential for anticonvulsant and antitrypsin activity, unlike their mother moiety, i.e., carbamazepine. The additional antibacterial activity effectively treats neurological disorders associated with bacterial infections.